市场调查报告书
商品编码
1611009
全球便携式筛检鼓室计市场 2024-2031Global Portable Screening Tympanometer Market 2024-2031 |
便携式筛检鼓室计市场规模、份额和趋势分析报告(按类型(成人鼓室计和儿童鼓室计)和应用(医院、诊所和体检中心)预测期(2024-2031)
在预测期内(2024-2031 年),便携式筛检鼓室计市场预计将以 6.1% 的复合年增长率成长。市场的成长归因于便携式筛检鼓室计的日益普及,因为它们便携、使用简单并且适用于各种医疗保健环境中的筛检。另一方面,桌面模型在需要彻底检查和诊断的临床环境中受到青睐。此外,全球听力损失病例的增加推动了市场的成长。根据世界卫生组织(WHO)2024年2月预测,到2050年,预计将有近25亿人出现一定程度的听力损失,其中至少7亿人需要听力復健。由于不安全的聆听习惯,超过 10 亿年轻人面临永久性、可避免的听力损失的风险。每人每年需要不到 1.4 美元的额外投资来扩大全球耳部和听力保健服务。 10 年内,每投资 1 美元,将获得近 16.0 美元的回报。
Portable Screening Tympanometer Market Size, Share & Trends Analysis Report by Type (Adult Tympanometer and Children Tympanometer), and Application (Hospital, Clinic and Physical Examination Center) Forecast Period (2024-2031)
The portable screening tympanometer market is anticipated to grow at a CAGR of 6.1% during the forecast period (2024-2031). The market growth is attributed to the growing prevalence of portable screening tympanometer, owing to their portability, simplicity of use, and applicability for screening in a range of healthcare settings. On the other hand, tabletop models are favored in clinical settings where thorough examinations and diagnosis are necessary. Additionally, increasing hearing loss cases globally drives the growth of the market. According to the World Health Organization (WHO), in February 2024, by 2050, nearly 2.5 billion people are projected to have some degree of hearing loss, and at least 700 million require hearing rehabilitation. Over 1 billion young adults are at risk of permanent, avoidable hearing loss owing to unsafe listening practices. An annual additional investment of less than $1.4 per person is needed to scale up ear and hearing care services globally. Over 10 years, this promises a return of nearly $16.0 for every US dollar invested.
Market Dynamics
Increasing Integration with Mobile Devices
Modern portable tympanometers frequently have Bluetooth or Wi-Fi connectivity, making data sharing and management easier. This allows data to be sent to smartphones or tablets. The reliability of screening results is increased by new models that provide faster and more accurate measurements. Healthcare workers will find it easier to use these devices with touchscreen displays and intuitive software as these are more commonplace. Smartphone-based tympanometry can provide information about middle ear function similar to commercial tympanometry. The portable nature of our system makes it a potentially viable option for use in developing countries, primary care clinics, and mobile health clinics.
Growing Adoption for Pediatric Screening
The demand for portable tympanometer in pediatric screening clinics and schools is being driven by an increasing emphasis on the early diagnosis of hearing problems in children. Regular hearing examinations for infants and young children are encouraged by several health programs and regulations, which further propels market expansion. Children with hearing loss may experience substantial developmental and quality-of-life setbacks. Screening criteria are in place to support clinicians. It is advised that all infants be screened for hearing loss by the time they are one month old, that they have diagnostic audiology testing by the time they are three months old, and that they receive appropriate intervention by the time they are six months old.
Market Segmentation
Adult Tympanometer is projected to hold the Largest Segment
The primary factors supporting the growth include increasing sensitivity and inexpensive, non-invasive, and simple methods for the diagnosis of middle ear disease among adults. Although low-frequency probes are most frequently used, the use of higher frequencies is increasingly gaining clinical acceptance, owing to its higher sensitivity for diagnosis of ossicular chain diseases. According to the National Institute on Deafness and Other Communication Disorders, in March 2024, approximately 15.0% of American adults (37.5 million) aged 18 and over report, some trouble hearing. Among adults ages 20-69 who report five or more years of exposure to very loud noise at work, about 18.0% have speech-frequency hearing loss in both ears. Among adults who report no occupational noise exposure, 5.5% have speech-frequency hearing loss in both ears. In the US, roughly 118,100 devices have been implanted in adults.
Hospital to Hold a Considerable Market Share
The factors supporting segment growth include the advanced diagnostic and treatment services offered by the hospitals, and the increasing demand for tympanometer in these settings, especially for neonatal hearing screening. Healthcare practitioners can evaluate middle ear function by using a hospital tympanometer, a medical equipment that measures the movement of the eardrum in response to changes in air pressure. This is accomplished by applying a precise amount of air pressure to the ear canal and recording the reflected sound waves. For instance, Hill-Rom Holdings, Inc. offers a Welch Allyn MicroTymp 4 Portable Tympanometer that helps to verify otoscopy findings and empowers diagnosis of middle ear conditions with objective evidence.
The global portable screening tympanometry market is further segmented based on geography including North America (the US, and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Growing Demand for Portable Screening Tympanometer in Asia-Pacific
The regional growth is attributed to the well-established healthcare infrastructure, high adoption rates of advanced medical technologies, and supportive reimbursement policies. Additionally, the increasing prevalence of hearing loss cases drives the growth of portable screening tympanometer. According to the National Council on Aging, in November 2023, Australia, China, Japan, and New Zealand) accounted for 136.5 million people-the highest contribution of any region-with a 7.1% prevalence for hearing loss.
North America Holds Major Market Share
North America holds a significant share owing to the presence of portable screening tympanometer offering companies such as Grason-Stadler (GSI) Inc., Hill-Rom Holdings, Inc., Natus Medical Inc., and others. The market growth is attributed to the increasing emphasis on middle ear diagnosis, mostly using tympanometry measurements. By changing the air pressure inside the ear canal, tympanometry is a non-invasive technique that assesses the middle ear's function, particularly the eardrums and the conduction bones' mobility. This diagnostic instrument helps detect diseases such as ruptured eardrums, Eustachian tube dysfunction, and otitis media (inflammation of the middle ear). As more people of all ages-children and adults alike-are experiencing ear-related problems, the portable screening tympanometer market has been steadily expanding. According to the National Institute on Deafness and Other Communication Disorders, in March 2024, 1 in 8 people in the US (13.0%, or 30 million) aged 12 or older have hearing loss in both ears, based on standard hearing examinations. About 5.0% of adults ages 45-54 have disabling hearing loss. The rate increases to 10.0% for adults ages 55-64. 22.0% of those ages 65-74 and 55.0% of those who are 75 and older have disabling hearing loss. As of July 2022, more than 1 million cochlear implants have been implanted globally. In the US, roughly 118,100 devices have been implanted in adults and 65,000 in children.
The major companies serving the portable screening tympanometry market include Grason-Stadler (GSI) Inc., Hill-Rom Holdings, Inc., Interacoustics A/S, MAICO Diagnostics GmbH, and Natus Medical Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market.